AU2021236446A1 - CRISPR-Cas-related methods, compositions and components for cancer immunotherapy - Google Patents

CRISPR-Cas-related methods, compositions and components for cancer immunotherapy

Info

Publication number
AU2021236446A1
AU2021236446A1 AU2021236446A AU2021236446A AU2021236446A1 AU 2021236446 A1 AU2021236446 A1 AU 2021236446A1 AU 2021236446 A AU2021236446 A AU 2021236446A AU 2021236446 A AU2021236446 A AU 2021236446A AU 2021236446 A1 AU2021236446 A1 AU 2021236446A1
Authority
AU
Australia
Prior art keywords
crispr
cas
compositions
components
related methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021236446A
Inventor
David A. Bumcrot
Ari E. FRIEDLAND
Morgan L. Maeder
G. Grant Welstead
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Editas Medicine Inc
Original Assignee
Editas Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Editas Medicine Inc filed Critical Editas Medicine Inc
Publication of AU2021236446A1 publication Critical patent/AU2021236446A1/en
Pending legal-status Critical Current

Links

AU2021236446A 2014-04-18 2021-09-20 CRISPR-Cas-related methods, compositions and components for cancer immunotherapy Pending AU2021236446A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61/981,636 2014-04-18
US62/138,246 2015-03-25

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2015247323A Division AU2015247323B2 (en) 2014-04-18 2015-04-17 CRISPR-Cas-related methods, compositions and components for cancer immunotherapy

Publications (1)

Publication Number Publication Date
AU2021236446A1 true AU2021236446A1 (en) 2021-10-21

Family

ID=

Similar Documents

Publication Publication Date Title
IL286103B (en) Crispr-cas-related methods, compositions and components for cancer immunotherapy
IL261163A (en) Crispr-cpf1-related methods, compositions and components for cancer immunotherapy
EP3589373A4 (en) Compositions and methods for immunotherapy
EP3286213A4 (en) Methods and compositions for combination immunotherapy
EP3242940A4 (en) Methods and compositions for combination immunotherapy
EP3240801A4 (en) Combination tumor immunotherapy
EP3092256A4 (en) Compounds and compositions for immunotherapy
EP3328375A4 (en) Methods for cancer and immunotherapy using glutamine analogues, including don
EP3129471A4 (en) Method and compositions for cellular immunotherapy
EP3186277A4 (en) Antibodies, compositions, and uses
EP3237003A4 (en) Nanoparticle compositions and methods for immunotherapy
EP3493827A4 (en) Compositions and methods for immunotherapy
EP3215520A4 (en) Cancer immunotherapy using virus particles
EP3160497A4 (en) Conjugates for immunotherapy
EP3247408A4 (en) Compositions and methods for cancer immunotherapy
EP3140305A4 (en) Novel compositions, uses and methods for making them
EP3215182A4 (en) Combination immunotherapy
EP3200815A4 (en) Methods and compositions for treating cancer
EP3096757A4 (en) Apilimod compositions and methods for using same
EP3500262A4 (en) Compositions and methods for cancer immunotherapy
EP3347025A4 (en) Methods and compositions for cancer treatment
EP3230302A4 (en) Carrier molecule compositions and related methods
EP3089992A4 (en) Compositions and methods for imaging cancer
EP3148564A4 (en) Methods and compositions for immunomodulation
EP3310915A4 (en) Tumor immunotherapy